A comparative effects of Dermaroller with Triamcinolone Acetonide v/s Dermaroller with platelet rich plasma v/s Dermaroller alone in treatment of patchy hair loss
Phase 4
- Conditions
- Health Condition 1: L639- Alopecia areata, unspecified
- Registration Number
- CTRI/2020/02/023471
- Lead Sponsor
- MGM Medical College and Hospital Aurangabad
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1)Clinically diagnosed case of Alopecia areata
2)Age 15-59 yrs
3)More than 2 patches of hair loss.
4)Agreeing to sign consent to be included in
Exclusion Criteria
1)Local disease such as folliculitis.
2)HIV, Hepatitis B or C, or otherwise immunocompromised patient.
3)History of Diabetes mellitus, Hypertension, any malignancy.
4)Pt under anticoagulant therapy.
5)Pt has taken NSAID within a week of visit .
6)Pregnant or nursing women .
7)Platelets less than 1.5 lakh/cmm.
8)Known allergy to Steroid
9)Any subject treated with a topical, intralesionalor systemic agent likely to cause regrowth in Alopecia areata within the past month
10) Alopecia totalis & universalis
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1) Growth of hair over patch of alopecia areata <br/ ><br>2) improvement in SALT scoring of alopecia areataTimepoint: 3 sittings at 3 weeks intervals followed by 3 followups at 1 month interval each
- Secondary Outcome Measures
Name Time Method 1) growth of Pigmented hair over patch of alopecia aretaTimepoint: 3 sittings at 3 weeks intervals followed by 3 followups at 1 month interval each